Halozyme Therapeutics (HALO) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free HALO Stock Alerts $38.57 +0.11 (+0.29%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMahesh Krishnan Elected to Halozyme's Board of Directorsprnewswire.com - April 25 at 4:45 PMCrossject reports audited financial results for 2023markets.businessinsider.com - April 25 at 7:32 AMHandelsbanken Fonder AB Purchases 222,200 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - April 25 at 6:43 AM3 Biotech Stocks That Could Be Multibaggers in the Making: April Editioninvestorplace.com - April 25 at 6:00 AMFY2026 EPS Estimates for Halozyme Therapeutics, Inc. (NASDAQ:HALO) Raised by Analystamericanbankingnews.com - April 25 at 2:36 AMZacks Research Comments on Halozyme Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:HALO)marketbeat.com - April 24 at 6:49 AMQ3 2025 Earnings Estimate for Halozyme Therapeutics, Inc. Issued By Zacks Research (NASDAQ:HALO)americanbankingnews.com - April 24 at 2:44 AMHalozyme to Report First Quarter 2024 Financial and Operating Resultsfinance.yahoo.com - April 23 at 9:39 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) to Post Q3 2025 Earnings of $1.01 Per Share, Zacks Research Forecastsmarketbeat.com - April 23 at 6:31 AMFederated Hermes Inc. Buys 292,926 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - April 23 at 5:35 AMLouisiana State Employees Retirement System Purchases New Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - April 22 at 5:12 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Holdings Raised by Kornitzer Capital Management Inc. KSmarketbeat.com - April 21 at 7:54 AMHC Wainwright Reaffirms Buy Rating for Halozyme Therapeutics (NASDAQ:HALO)americanbankingnews.com - April 20 at 7:04 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Knights of Columbus Asset Advisors LLCmarketbeat.com - April 19 at 1:38 PMMichael J. Labarre Sells 10,000 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stockinsidertrades.com - April 19 at 4:50 AMHalozyme Therapeutics CTO sells $768,390 in stockinvesting.com - April 19 at 12:30 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Michael J. Labarre Sells 10,000 Sharesinsidertrades.com - April 18 at 6:32 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Sells $384,900.00 in Stockmarketbeat.com - April 17 at 9:22 PMBuy Rating Affirmed for Halozyme on OCREVUS SC Prospects and Enhanze Technology Potentialmarkets.businessinsider.com - April 17 at 6:09 PMHalozyme Therapeutics' (HALO) Buy Rating Reiterated at HC Wainwrightmarketbeat.com - April 17 at 4:27 PMHalozyme Therapeutics' (HALO) "Buy" Rating Reaffirmed at Benchmarkamericanbankingnews.com - April 17 at 4:46 AM9 Analysts Have This To Say About Halozyme Therapeuticsmarkets.businessinsider.com - April 16 at 1:02 PMAllspring Global Investments Holdings LLC Lowers Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - April 14 at 5:36 AMHarvey Capital Management Inc. Invests $5.92 Million in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - April 12 at 5:41 PMHalozyme's Strategic Partnerships Fueling Next-Gen Therapeuticsseekingalpha.com - April 10 at 6:50 AMValidea Detailed Fundamental Analysis - HALOnasdaq.com - April 10 at 12:59 AM3 Biotech Stocks to Buy in 2024stocknews.com - April 9 at 6:02 PMAnalysts Offer Insights on Healthcare Companies: Halozyme (HALO) and MacroGenics (MGNX)markets.businessinsider.com - April 8 at 1:12 PMResearch Analysts Offer Predictions for Halozyme Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:HALO)marketbeat.com - April 5 at 8:06 AMIs Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?finance.yahoo.com - April 4 at 9:44 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Position Lowered by Redwood Investments LLCmarketbeat.com - April 1 at 6:48 AMMirum Pharmaceuticals (MIRM) Down 12.5% Since Last Earnings Report: Can It Rebound?finance.yahoo.com - March 29 at 3:11 PMThe 3 Best Biotech Stocks to Buy in Q2 2024investorplace.com - March 29 at 6:40 AMFate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?finance.yahoo.com - March 27 at 3:29 PMWellington Management Group LLP Has $5.95 Million Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 26 at 4:17 AMVanguard Group Inc. Sells 29,621 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 24 at 4:30 AMZacks Research Analysts Raise Earnings Estimates for Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 20 at 6:54 AMQ2 2025 Earnings Forecast for Halozyme Therapeutics, Inc. Issued By Zacks Research (NASDAQ:HALO)marketbeat.com - March 19 at 7:14 AMHALO Apr 2024 35.000 putfinance.yahoo.com - March 16 at 7:36 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Expected to Earn Q1 2024 Earnings of $0.71 Per Sharemarketbeat.com - March 15 at 7:20 AMInsider Selling: Halozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Sells 10,000 Shares of Stockmarketbeat.com - March 13 at 7:34 PM7 Biotech Stocks to Buy as Sector Rotation Ramps Upinvestorplace.com - March 13 at 2:25 PMI:RUT Mar 2024 Weekly 1905.000finance.yahoo.com - March 12 at 9:17 AMAurora Investment Counsel Buys Shares of 35,261 Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 11 at 1:31 PMTD Cowen Reaffirms Their Buy Rating on Halozyme (HALO)markets.businessinsider.com - March 8 at 4:16 PMAdage Capital Partners GP L.L.C. Acquires Shares of 400,000 Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 8 at 7:27 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Purchased by Kennedy Capital Management LLCmarketbeat.com - March 5 at 3:41 PMEnvestnet Asset Management Inc. Raises Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 4 at 5:01 AMTD Cowen Initiates Coverage of Halozyme Therapeutics (HALO) with Outperform Recommendationmsn.com - March 1 at 9:14 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Mariner LLCmarketbeat.com - March 1 at 5:32 AM Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy HALO Media Mentions By Week HALO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HALO News Sentiment▼1.010.32▲Average Medical News Sentiment HALO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HALO Articles This Week▼205▲HALO Articles Average Week Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EXEL News Today RLAY News Today ALLO News Today RGEN News Today NVAX News Today FATE News Today ADPT News Today KOD News Today NBIX News Today KRYS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HALO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
